Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Indiva Ltd NDVAF


Primary Symbol: V.NDVA.H

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron... see more

TSXV:NDVA.H - Post Discussion

Indiva Ltd > This is the bottom
View:
Post by Duster340 on Jul 19, 2022 2:21pm

This is the bottom

in my opinion, only goes higher from here. Q2 a month away, is it possible they have a surprise in revenue to the possitve side,  under promise over deliver maybe done deliberately, i know they are frustated with the stock price just like bruce campbell is. but what better way to stir up interest in the stock followed by strong guidance for Q3 and Q4. i think the stock moves higher before the release of Q2 and then pops when the financials are released, on revenue and mostly on Q3 + Q4 guidance my advice get in early.
glta

Corporate Update

The Company has received strong initial orders from the Ontario Cannabis Store ("OCS") for the load-in and launch of Grn Pearls gummies in Ontario . Initial deliveries of the first four Pearls gummie SKUs will occur in July 2022 and include unique flavours and cannabinoid profiles such as Blue Razzleberry 3:1 CBG:THC, Blackberry Lemonade 1:1:1 CBN:CBD:THC, Pomegranate 4:1 CBD:THC, and Sour Green Apple THC. Each container will contain five sugar-coated sphere-shaped gummies. Deliveries of Pearls to additional provinces is expected to occur in late Q3.

Indiva recently received final confirmation from the OCS for the listing of an additional 25 new SKUs, including five SKUs which will participate in the "Flow-through" program. These additional listings bring Indiva's OCS listings to a total of 60 SKUs, up from the current level of 35 SKUs. The newly accepted SKUs are across six brands: Indiva Life(including lozenges, cookies and chocolates), Artisan Batch, Grn Pearls (including three SKUs in addition to the initial four Pearls SKUs slated for the July launch described above), Grn Pips, Dime Vapes and Bhang Chocolate. All SKUs are expected to launch in Ontario in September and October 2022 , as well as additional provinces beginning in Q3.

Comment by nedstar71 on Jul 19, 2022 3:28pm
So you're suggesting that June 27th the company deliberately lied about the lower revenue guidance, in order to surprise to the upside? You can't be serious. I can assure you this company doesn't operate that way and if they did they'd have a heck of a lot more issues than lower revenue to deal with.
Comment by Duster340 on Jul 19, 2022 11:58pm
Duster340 Writes: nope not suggesting they lied at all, but they could have projected very conservative #'s for the quarter. i have seen this before many times where a company blows there previously reported guidence out of the water. it is not unusual at all. nor is it shady.
Comment by Inthepez on Jul 21, 2022 4:27pm
Don't ever trust this troll. He has multiple aliases and posts the same nonsense. If you need you ever needed confirmation please see this post. Caught posting the same exact thing on 2 different boards using different aliases. Lying creep. https://stockhouse.com/companies/bullboard/t.ate/antibe-therapeutics?threadid=34827076
Comment by davgro on Jul 20, 2022 1:24am
The facts here are very straightforward.  On May 19th, 2022, the company stated in its Q1 2022 financial reporting: "The company expects Q2 2022 net revenue to be higher sequentially, driven by new product introduction and continued strength in the company's core products." In a subsequent corporate update issued on June 27th, 2022 the company stated: "The company also ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities